Use of cookies

Lund University uses cookies to ensure that the website functions properly and to improve your experience.

Read more in our cookie policy

Search results

Filter

Reset filter

Filetype

Your search for "*" yielded 125241 hits

Selected publications

VEGF-C-expressing TAMs rewire the metastatic fate of breast cancer cells.Banerjee K, Kerzel T, Bekkhus T, Ferreira de Souza S, Wallmann T, Wallerius M, Landwehr LS, Agardy DA, Schauer N, Malmerfeldt A, Bergh J, Bartish M, Hartman J, Östman A, Squadrito ML and Rolny C. Cell Reports. 2023 Dec 1;42(12):113507. doi: 10.1016/j.celrep.2023.113507  MNK2 governs the macrophage antiinflammatory phenotype.B

https://www.tcr.lu.se/research-groups/charlotte-rolny/selected-publications - 2025-12-07

Molecular Pediatric Oncology

PI Daniel Bexell Our researchOur research is about childhood cancer neuroblastoma. We work to understand the mechanisms leading to metastasis and treatment resistant relapse, and to test new treatment against aggressive neuroblastoma. Our projects encompass studies on basic tumor biology as well as preclinical and translational studies with the aim to find novel treatments. We perform molecular an

https://www.tcr.lu.se/research-groups/molecular-pediatric-oncology - 2025-12-07

Molecular Tumor Pathology

PI Ramin Massoumi Our researchThe overall goal of our research is to characterize the function of certain genes in development biology and immunology. In addition, we try to identify driver genes that are defined as being linked to human diseases such as cancer and fibrosis. Dissecting the signalling pathway with the focus on the post-translational modifications, will allow us to identify potentia

https://www.tcr.lu.se/research-groups/molecular-tumor-pathology - 2025-12-07

Brain Tumor Biology

PI Alexander Pietras BackgroundGlioblastoma multiforme (GBM) the highest-grade glioma and deadliest brain tumor occurs in pediatric as well as adult patients. Despite aggressive treatment with surgery, irradiation and sometimes chemotherapy, tumors invariably recur as incurable lesions. Tumor cells with stem cell characteristics are thought to be responsible for therapeutic resistance in brain tum

https://www.tcr.lu.se/research-groups/brain-tumor-biology - 2025-12-07

Experimental Oncology

PI Kristian Pietras Our researchOur aim is to molecularly map support functions performed by the various cell types comprising the tumor microenvironment. We believe that decisive treatment benefit can only be achieved by targeting several of the cell types that collectively sustain tumor growth. Importantly, the cellular networks within tumors cannot be studied in isolation. Thus, our work ranges

https://www.tcr.lu.se/research-groups/experimental-oncology - 2025-12-07

Molecular Cancer Research

PI Lars Rönnstrand BackgroundThe receptor tyrosine kinases KIT and FLT3 are both important regulators of development and maintenance of a number of different cell types. Deregulation of these receptors by mutations has been implicated in various human malignancies, including akut myeloid leukemia and melanoma. The signaling pathways activated by the oncogenic mutants are to some extent unique and

https://www.tcr.lu.se/research-groups/molecular-cancer-research - 2025-12-07

Molecular Cancer Medicine

PI Kazi Julhash Uddin BackgroundDespite incredible progress in the treatment of cancer, the cure rate remains low due to the fact that almost all cancer patients develop resistance to anticancer therapies.  This results in as many as 90% of cancer-related deaths in various types of cancer. Consequently, identification of the factors that drive the development of therapy resistance is a pressing is

https://www.tcr.lu.se/research-groups/molecular-cancer-medicine - 2025-12-07

Contact

Joakim Esbjörnsson, PhDAssociate Professor in VirologySenior Lecturer in Medical MicrobiologyHead of Systems Virology GroupDepartment of Translational MedicineFaculty of MedicineLund UniversityPostal address:Lund UniversityBMC, B13221 84 LundSwedenPhone: +46 46 22 20119, Officeemail: joakim [dot] esbjornsson [at] med [dot] lu [dot] se   Honorary Visisting Research Fellow Nuffield Department of Med

https://www.virology.lu.se/contact - 2025-12-07

Projects

Acute HIV-1 infectionViral evolution and innate immune responses during acute adult HIV-1 infection and their association with disease pathogenesisIt has been suggested that different virological and immunological events during the very early stages of HIV infection may determine the rate of the future disease course of the individual patient. Previous studies by us and others have suggested that

https://www.virology.lu.se/virology.lu.se/systems-virology - 2025-12-07

Systems Virology

Long-standing collaboration and fieldwork in Guinea-Bissau, West Africa, has made Lund University one of the leading institutions in the world when it comes to HIV-2 research. The virology research in Lund has access to multiple high-end experimental platforms encapsulating molecular as well as cell biology techniques to support cutting-edge HIV research. This also includes modern BSL-3 facilities

https://www.virology.lu.se/systems-virology - 2025-12-07

The Clinical Virology Team

Patrik Medstrand Professor Read about Patrik in the Research Portal Patrik´s publications                               Sara Karlson    Senior Laboratory Assistant   MSc. Biomedicine   Read about Sara in the Research Portal   Sara's publications " HIV research has always been very intriguing to me and this contributes to my long-term interest in the field. Working as a lab technician for three dif

https://www.virology.lu.se/clinical-virology/clinical-virology-team - 2025-12-07

The HIV Host Interactions Team

  Marianne JanssonPhD, Professor Read about Marianne in the Research PortalMarianne´s publications "My research is focused on understanding HIV host interactions and the impact these have on disease progression, by deciphering mechanisms behind protective and pathogenic immune responses in HIV-1 and HIV-2 infections. The goal is to contribute to optimized treatment and provide clues to how an effe

https://www.virology.lu.se/hiv-host-interactions/hiv-host-interactions-team - 2025-12-07